A Trial of ALN-6457 in Adult Participants with Symptomatic Prion Disease
Families affected by prion disease, join us for a webinar with Regeneron Pharmaceuticals as they prepare for the launch of their clinical trial.
The presentation will be followed by a live Q&A with Andreja Avbersek, MD, PhD, Executive Medical Director, Regeneron Pharmaceuticals.
To register, contact the CJD Foundation at help@cjdfoundation.org or 800-659-1991.
This is a live session only and will not be recorded or available for later viewing.